Chemotherapy in Navi Mumbai

Chemotherapy

Chemotherapy is a medical treatment that uses powerful drugs to destroy cancer cells. It works by targeting and killing cells that grow and divide quickly. Because these medicines travel through your whole bloodstream, they can reach cancer cells anywhere in your body. Chemotherapy is not a single experience. It looks very different depending on the condition being treated, the drugs involved, and the individual patient in front of us. UMC Hospitals offers reliable chemotherapy treatment in Navi Mumbai that offers relief for cancer patients.

Unlike solid tumours confined to one organ, blood cancers - leukaemia, lymphoma, multiple myeloma- circulate through the body's entire haematopoietic system. Chemotherapy works by targeting rapidly dividing cells, disrupting their ability to replicate. In conditions like acute leukaemia, where abnormal white cells proliferate aggressively within the bone marrow and peripheral blood, chemotherapy is often the most immediate and necessary intervention.

The drugs are delivered in cycles - typically administered intravenously over several hours, followed by a recovery period that may last one to three weeks. This rhythm gives healthy cells time to recover while continuing to suppress malignant ones. Some regimens involve oral medications taken at home. Others require inpatient admission. The approach depends entirely on the diagnosis, disease stage, and the patient's overall condition.

Over the past decade, haematology has genuinely been transformed by targeted therapies. These are not conventional chemotherapy drugs. They work by identifying and blocking specific molecular abnormalities driving the cancer, a fundamentally different mechanism. In chronic myeloid leukaemia, for instance, tyrosine kinase inhibitors have replaced aggressive chemotherapy for many patients, allowing them to manage their condition with a daily oral tablet and a largely normal quality of life.

Biological treatments, including monoclonal antibodies, work by enlisting the body's own immune system to recognize and destroy malignant cells. Rituximab, used widely in lymphoma treatment, is one such example that has significantly improved patient outcomes over the years. These therapies carry a different side effect profile compared to conventional chemotherapy, though they are not without their own considerations.

Key targeted and biological treatments used in haematology include:

  • Tyrosine kinase inhibitors - commonly used in chronic myeloid leukaemia and certain leukaemias with specific genetic mutations
  • Monoclonal antibodies - such as rituximab in lymphoma and daratumumab in multiple myeloma
  • Proteasome inhibitors - used in myeloma treatment to block the cellular machinery that cancer cells depend on
  • BCL-2 inhibitors - increasingly used in chronic lymphocytic leukaemia and certain other blood cancers

Immunotherapy has added another important dimension to haematological oncology. CAR-T cell therapy, where a patient's own T-cells are extracted, genetically modified in a laboratory to recognise cancer cells, and reinfused, has shown remarkable results in certain relapsed or refractory blood cancers. It is not yet universally available, and patient selection requires careful evaluation, but it represents a genuinely significant development in how we approach difficult cases.

Checkpoint inhibitors, another class of immunotherapy, are increasingly being explored in lymphoma and other haematological malignancies. The field is moving quickly, and what was considered experimental a few years ago is now becoming part of standard protocols.

Before chemotherapy begins, a thorough pre-treatment evaluation is carried out - baseline blood counts, organ function tests, cardiac assessment where relevant, and a detailed discussion with the patient and their family about what the coming weeks will involve. Port or PICC line insertion may be recommended for patients requiring prolonged intravenous therapy, avoiding repeated cannulation and protecting peripheral veins.

During treatment, patients commonly experience:

  • Fatigue — among the most consistently reported symptoms across all chemotherapy regimens
  • Nausea — manageable in most patients with modern antiemetic support
  • Hair loss — occurs with certain regimens, but not all
  • Mouth sores and low blood counts — require regular monitoring throughout the treatment cycle
  • Fever above 38°C — must be reported promptly, as neutropenic fever requires immediate clinical attention

Consult our team at UMC Hospitals for reliable cancer treatment in Navi Mumbai.

Maintaining adequate caloric and protein intake during treatment is important and often harder than it sounds. Appetite changes, taste alterations, and persistent fatigue all interfere with regular eating patterns. Practically speaking:

  • Small, frequent meals are better tolerated than large ones
  • Staying well hydrated supports kidney function and reduces certain drug-related side effects
  • Protein-rich foods help support tissue repair and immune function during treatment
  • Patients are advised to avoid raw or undercooked foods during periods of low immunity

Choosing where to receive chemotherapy and other cancer treatment care is one of the most important decisions a patient and their family will make. At our Department of Haematology, you will find more than clinical excellence - you will find a team that listens, a care plan built around you, and an unwavering commitment to support you through every stage of your journey, from diagnosis to recovery. UMC Hospitals offers advanced chemotherapy treatment in Navi Mumbai for patients with cancer.